Subclinical carotid atherosclerosis and cardiovascular risk factors in HIV-infected patients
Related Experiment Video
Updated: May 26, 2026

Quantification of Cerebral Vascular Architecture using Two-photon Microscopy in a Mouse Model of HIV-induced Neuroinflammation
Published on: January 12, 2016
Wiesława Kwiatkowska1, Brygida Knysz, Justyna Drelichowska-Durawa
1Department of Angiology, Regional Specialist Hospital in Wroclaw, Research and Development Center, Poland. kwiatkowska_w@interia.pl
Insights
HIV patients on antiretroviral therapy have increased cardiovascular disease risk due to more advanced subclinical atherosclerosis. Key factors influencing carotid intima-media thickness (cIMT) include age, hypertension, cholesterol, and ARV treatment duration.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- HIV infection and antiretroviral (ARV) drug use are associated with elevated cardiovascular disease (CVD) risk.
- Subclinical atherosclerosis, a precursor to CVD, requires further investigation in HIV-positive individuals.
Purpose of the Study:
- To assess carotid artery subclinical atherosclerosis progression (carotid intima-media thickness [cIMT] and plaque incidence) in HIV patients.
- To analyze the relationship between cIMT and cardiovascular disease risk factors within this cohort.
Main Methods:
- Comparative analysis of 72 HIV-infected patients and 27 HIV-negative controls, matched for age and sex.
- Data collection included HIV/ARV status, cardiovascular risk factors, and carotid artery ultrasound (cIMT, plaque assessment).
Main Results:
- HIV patients exhibited more advanced carotid atherosclerosis (higher cIMT and plaque incidence).
- Significant differences in cardiovascular risk profiles were observed, including lower BMI, higher WHR, altered lipid profiles (lower cholesterol, higher triglycerides), and increased smoking prevalence.
- cIMT strongly correlated with age, hypertension, non-high-density lipoprotein (non-HDL) cholesterol, and ARV duration. Total cholesterol, LDL cholesterol, and lifetime smoking also impacted cIMT.
Conclusions:
- HIV-infected individuals, particularly those on ARV therapy, display accelerated subclinical atherosclerosis.
- Cardiovascular risk factor management and monitoring are crucial in HIV patients to mitigate atherosclerosis progression.
Background:
HIV infected patients, especially those treated with antiretroviral (ARV) drugs, show an increased risk and incidence of cardiovascular disease.
Objectives:
The aim of this study was to evaluate the progression of subclinical atherosclerosis in the carotid arteries, expressed as the value of carotid intima-media thickness (cIMT) and the amount of atherosclerotic plaques, and to analyze the correlation between cIMT and risk factors for cardiovascular diseases in a cohort of HIV infected patients.
Methods:
The analysis included 72 HIV infected patients, mean age 39.4 years, and 27 healthy HIV negative individuals, matched for age and sex. The data collected included evaluation of the infection, ARV treatment, past cardiovascular events, assessment of traditional and nontraditional risk factors for cardiovascular diseases, cIMT measurements and amount of atherosclerotic plaques in the carotid arteries.
Results:
HIV infected patients show more advanced subclinical atherosclerosis in the carotid arteries (cIMT and plaques incidence). The cardiovascular risk profile of the HIV infected patients is significantly different from HIV negative people. Among the HIV positive group lower body mass index (BMI) and higher waist/hip ratio (WHR) are observed. The concentration of all cholesterol fractions is lower, whereas the concentration of triglycerides is higher. Cigarette smoking is more common among HIV-infected individuals. A strong statistical correlation between cIMT and age, hypertension, non-high-density lipoprotein (non-HDL) cholesterol and ARV time were found. Total and LDL cholesterol, and lifetime smoking exposure also affect the cIMT. The relationship between cIMT and current HIV RNA may indicate the impact of the current infection status on the cIMT dynamics in this subpopulation.
More Related Videos
05:53Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
09:41Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
Related Concept Videos
Coronary Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease III: Clinical Manifestations
Atherosclerosis III: Management
Sexually Transmitted Infections
Atherosclerosis I: Introduction